IP Library Granted Patent US 11,268,079
Granted Patent B2
US 11,268,079 · App. 16/528,292 · Granted Mar 8, 2022

Compositions of beta-glucuronidase enzyme blends with enhanced enzymatic activity and methods of preparation thereof

Inventors: John Tomashek (Columbia, SC); Caleb Reece Schlachter (Irmo, SC); Pongkwan Sitasuwan (Columbia, SC); Lim Andrew Lee (Columbia, SC)
Assignee: INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
C12N9/2405C12Q1/005C12Q1/37C12Y301/06001C12Y302/01031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,268,079
App. No.
16/528,292
Granted
Mar 8, 2022
Kind
B2
Abstract

Blends of enzymes of the same enzyme class (same EC number), such as beta-glucuronidase enzyme blends, are provided that exhibit synergistic levels of activity across a range of substrates as compared to the activity levels of each enzyme in the blend individually. The blends also may exhibit a greater effective substrate range, as well as greater effective pH and/or temperature ranges as compared to single enzyme preparations. Predictive methods for determining optimal enzyme blends, methods for preparing enzyme blends, enzyme blend compositions, enzyme blend formulations and methods of using such enzyme blends are provided.

Claims (17)

1. A composition comprising a blend of Brachyspira pilosicoli beta-glucuronidase (BpGUS) and Eubacterium eligens beta-glucuronidase (EeGUS), wherein:

(a) the blend comprises about 10%-30% BpGUS and about 70%-90% EeGUS; or

(b) the blend comprises about 15%-25% BpGUS and about 75%-85% EeGUS; or

(c) the blend comprises 15% BpGUS and 85% EeGUS; or

(d) the blend comprises 25% BpGUS and 75% EeGUS; and

wherein BpGUS comprises the amino acid sequence shown in SEQ ID NO: 5 and EeGUS comprises the amino acid sequence shown in SEQ ID NO: 10.

2. A formulation comprising the composition of claim 1 , wherein the formulation comprises the enzyme blend and at least one excipient, wherein each enzyme in the blend is present at a concentration of at least 0.1 mg/mL.

3. The formulation of claim 2 , wherein:

(a) the formulation is an aqueous formulation;

(b) the formulation is a lyophilized formulation;

(c) the at least one excipient is selected from the group consisting of water, salts, buffers, sugars and amino acids; and/or

(d) the formulation is free of polymers and detergents.

4. A packaged formulation comprising the formulation of claim 2 and a container.

5. The composition of claim 1 , wherein the blend comprises about 10%-30% BpGUS and about 70%-90% EeGUS.

6. The composition of claim 1 , wherein the blend comprises about 15%-25% BpGUS and about 75%-85% EeGUS.

7. The composition of claim 1 , wherein the blend comprises 15% BpGUS and 85% EeGUS.

8. The composition of claim 1 , wherein the blend comprises 25% BpGUS and 75% EeGUS.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2019
From: TOMASHEK, JOHN; SCHLACHTER, CALEB REECE; SITASUWAN, PONGKWAN; LEE, LIM ANDREW
To: INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
Reel/Frame 050013/0755 →
Continuity (3)
Provisional Application 62754358 · Nov 1, 2018
Provisional Application 62713188 · Aug 1, 2018
Related Publication 20200040319A1 · Feb 6, 2020
Cited By (1)
US 12,252,719